버거씨 병(Buerger's Disease) 환자에서 하지지 동맥 우회로술 및 교감신경 차단술과 함께 이용된 동맥 내 프로스타글란딘 직접 투여

Intra-arterial Direct Prostaglandin Infusion Combined with Lower Limb Arterial Bypass Graft and Lumbar Sympathectomy for Treating Buerger's Disease

  • 이길수 (강원대학교 의과대학 흉부외과학교실, 강원대학교병원 임상의학연구소) ;
  • 류세민 (강원대학교 의과대학 흉부외과학교실, 강원대학교병원 임상의학연구소) ;
  • 조성준 (강원대학교 의과대학 흉부외과학교실, 강원대학교병원 임상의학연구소) ;
  • 이서영 (강원대학교 의과대학 신경과학교실, 강원대학교병원 임상의학연구소)
  • Yie, Kil-Soo (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) ;
  • Ryu, Se-Min (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) ;
  • Cho, Seong-Joon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) ;
  • Lee, Seo-Young (Department of Neurology, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
  • 발행 : 2008.08.05

초록

서구인에 비해 동양인, 특히 극동지방의 버거씨 발병률은 높으나 우회로술 단독만의 성적은 아직 만족할 만하지 못하다고 알려져 있다. 따라서 우회론수술과 함께 교감신경 차단술, 금연, 정맥 내 혈관 확장제 투여 등의 보다 적극적이고 다양한 치료법이 요구되고 있다. 본 논문은 49세의 버거씨병 환자에게 복제정맥을 이용한 대퇴동맥-슬와동맥간 우회로술 및 교감 신경 차단술과 함께 동맥 내(intra-arterial) 프로스타글란딘 투여를 시행한 증례이다.

The incidence of the Buerger's disease is higher for the far-East Asian population that for western people, but the surgical outcomes have been documented to be unsatisfactory. So, more aggressive and multi-focused treatment modalities should be warranted such as stopping smoking or intravenous vasodilator infusion with surgery. We report here on a successful surgical case of intra-arterial direct infusion of Prostaglandin E1 concomitant with surgical bypass and lumbar sympathectomy to treat Buerger's disease.

키워드

참고문헌

  1. Jeffry WO. Thromboangitis obliterans: rutherford. Vascular Surgery. 6th ed. Philadelphia: Elsevier Saunders Co. 2005.
  2. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998;124:498-502. https://doi.org/10.1016/S0039-6060(98)70095-9
  3. Park JS, Kim KU. Buerger's disease in Korea. Korean J Vasc Surg 2005;21:105-12.
  4. Shionoya S. Buerger's disease: Diagnosis and management. Cardiovasc Surg 1993;1:207-15.
  5. De Giacomo T, Rendina EA, Venuta F. Thoracoscopic sympathectomy for symptomatic arterial obstruction of the upper extremities. Ann Thorac Surg 2002;74:885-8. https://doi.org/10.1016/S0003-4975(02)03806-7
  6. Okuda Y, Kitajima T. The effects of combined sympathetic block and intravascular infusion of prostaglandin E1 on brachial arterial blood flow in dogs. Anesth Analg 1999; 89:1514-6. https://doi.org/10.1097/00000539-199912000-00037
  7. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential on peripheral vascular disease, myocardial ischemia andd extracorporeal circulation procedures. Drugs 1992;43: 889-95. https://doi.org/10.2165/00003495-199243060-00008
  8. The European TAO Study Group. Oral iloprost in the treatment of thromboangitis obliterans (Buerger' s disease): a double-blind, radomised, placebo-controlled trail. Euro J Vasc Surg 1998;15:300-6. https://doi.org/10.1016/S1078-5884(98)80032-4